COVID-19 Project Selection
Committee

Doug Buchanan

Committee CHair | M.Sc. , MBA,

For more than twenty years, Doug Buchanan was the Managing Director & CEO of BC Biomedical Laboratories Ltd. He provided leadership to all functional areas of the practice and led significant changes in the organization, including several acquisitions, and the development of a new, leading-edge laboratory. Read more

Dr. Catalina Lopez-Correa

COO at Ruta N Medellin

With more than 20 years of international experience in both the academic and private sectors, Dr. Catalina Lopez-Correa’s deep understanding of genomics and innovation has inspired leaders in science and industry to collaborate toward solving some of the world’s greatest challenges. Read more

Tara McCarville

Principal, Brighton Group

Tara McCarville is a Principal Consultant at Brighton Group, a health industries solutions firm. As the former National Health Industries Leader for PwC Canada, Tara was accountable for leading a national practice focused on improving quality and outcomes for government, hospital, healthtech/medtech, home/long term care, and private equity clients. Read more

Alan E Winter

PhD, FCAE​

Alan Winter was British Columbia’s first Innovation Commissioner from 2018-2020. He has wide experience at senior levels in the technology sector and in government. Dr Winter has been a director of over 30 organizations and companies.  Read more

Sally Daub

Founder & Managing Partner, Pool Global Partners

Sally Daub is a technology entrepreneur, venture capitalist and CEO with experience in semiconductors, consumer electronics, healthcare, quantum computing and blockchain. As Founder and Managing Partner of Pool Global Partners, Sally is investing in the next generation of deep-tech innovation and supporting founders by sharing her expertise. Read more

Dr. Geoff Houlton

Mentor| Consultant | Advisor

Dr Houlton qualified in medicine from Ninewells Medical School at the University of Dundee. Following residency training in anesthesiology he joined the pharmaceutical industry in the UK as a medical advisor in product development. He was recruited to Canada to lead the development of the Medical Affairs Department of Glaxo Canada Inc. now Glaxo SmithKline (GSK). Read more